Tag Archives: provincial drug plans

How To Get Kalydeco Funded In Canada

So – finally! – after Health Canada approved Kalydeco in November 2012 for use in Canada by CF patients aged six years and older who have the specific G551D mutation, it now appears this brilliant new medication will soon be … Continue reading

Posted in Cystic Fibrosis | Tagged , , , , , , , | Leave a comment

Vertex Statement Following Meeting With Provincial Health Ministers

On Tuesday, May 13, Vertex met in Toronto with the Health Ministers from Alberta and the Yukon as part of our ongoing discussions regarding the public reimbursement of KALYDECO in Canada. “While we had a lengthy discussion, we have not … Continue reading

Posted in Cystic Fibrosis | Tagged , , , , | Leave a comment

Canadians are Paying more for Prescription Drugs than other Countries

While this country is still waiting for the Pan-Canadian Purchasing Alliance (PCPA) and Vertex Pharmaceuticals to come to an agreement regarding the cost of Kalydeco, Health Ministers of Ontario, Alberta and Yukon want to meet with the chief executive of … Continue reading

Posted in Cystic Fibrosis | Tagged , , , , | Leave a comment

Good News About Kalydeco From Nova Scotia

Today we finally (!) had some good news regarding the funding of Kalydeco. In an interview with CBC’s Elizabeth Chiu, Nova Scotia Health Minister Leo Glavine stood up for CF patients, like Carys Nurse and Tim Vallillee, and committed to … Continue reading

Posted in Cystic Fibrosis | Tagged , , , , , , , | Leave a comment